MYREMEDYUM SL
Company details
- Active NIF/CIF: B01735182
-
-
-
-
Address: AVDAFINISTERRE 265-C 3º (CORUÑA (A)).
-
-
Featured products:
More information on MYREMEDYUM SL
-
VALDES VILCHES DANIELAdministrador mancomunadoAppointment: 30/07/2020
-
CASAL SANCHEZ CARLOS-ANTONIOAdministrador mancomunadoAppointment: 30/07/2020
-
RODRIGUEZ MATEOS MARIA BELENAdministrador mancomunadoAppointment: 30/07/2020
-
ABRIL GOMEZ JOSE-LUISAdministrador mancomunadoAppointment: 30/07/2020
-
MORENO SAAVEDRA MARIA- ELENAAdministrador mancomunadoAppointment: 30/07/2020
-
14/11/2024 | BORME act no.: 487515 | Register: A CORUÑAModificaciones estatutarias
-
14/11/2024 | BORME act no.: 487515 | Register: A CORUÑACambio de domicilio social
-
30/07/2020 | BORME act no.: 247285 | Register: A CORUÑAConstitución
-
30/07/2020 | BORME act no.: 247285 | Register: A CORUÑANombramientos
Other information
The CIF assigned to MYREMEDYUM SL is B01735182, and its commercial status is active. The company is engaged in economic activities classified under the CNAE -. Additionally, it is categorized with the SIC code -.
MYREMEDYUM SL employs approximately Between 1 and 9 employees and records an annual turnover of less than 2 million euros. The company is registered in the Commercial Registry of A coruña, and has 5 registration charges. The most recent announcement in Borme was published on 14/11/2024, while the last deposit of ordinary annual accounts corresponds to the year 2023.
To find out the contact information of MYREMEDYUM SL, such as the telephone number, postal address, or website, you can access the Company Data module.
If you wish to obtain additional information about MYREMEDYUM SL, we invite you to consult any of the available financial reports, the Annual Accounts of the company, or review the incidents of defaults registered in the RAI delinquency file.
The financial, commercial, and legal information about MYREMEDYUM SL comes from official data sources and is automatically updated every day.
Do you want to know more about MYREMEDYUM SL??
Find out more about this company by consulting these reports: